share_log

Glucose Health, Inc. Corporate Update

Glucose Health, Inc. Corporate Update

葡萄糖健康公司公司最新消息
GlobeNewswire ·  2022/03/18 03:06

BENTONVILLE, AR, March 17, 2022 (GLOBE NEWSWIRE) -- Glucose Health, Inc. (OTC Pink: GLUC)  ("Company") announced today, it has accepted the resignations of Hal Kravitz and John Fieldly from the Company's board of directors.     

環球新聞網阿肯色州本頓維爾2022年3月17日電葡萄糖健康公司(場外交易市場代碼:GLUC)(以下簡稱“公司”)今天宣佈,它已接受哈爾·克拉維茨和約翰·菲爾德利辭去公司董事會的職務。

About Glucose Health, Inc.

關於葡萄糖健康公司

Manufactured by Glucose Health, Inc., the GLUCODOWN® brand is defining a new beverage industry category – functional, diabetic friendly, beverages. By specializing in producing healthy and delicious beverages, nutritionally appropriate1 for the nation's 100+ million2 pre and Type-2 diabetics, and additionally in 2022, launching a new healthy and delicious ready-to-drink beverage formulated to meet the nutritional needs of 45+ consumers, Glucose Health, Inc. is uniquely positioned among all emerging beverage companies in America.

由葡萄糖健康公司生產的GLUCODOWN®品牌正在定義一個新的飲料行業類別--功能性、糖尿病友好型飲料。通過專業生產健康美味的飲料,營養適合全國1億多名2型糖尿病患者,並在2022年推出一種新的健康美味即飲飲料,以滿足45+消費者的營養需求,葡萄糖健康公司在美國所有新興飲料公司中處於獨特的地位。

For more news, visit 
Like us on Facebook at 
1 For citations visit 
National Diabetes Statistics Review, 2020; Centers for Disease Control and Prevention, Department of Health and Human Services
Contact:
Murray Fleming
Glucose Health, Inc.
info@glucosehealthinc.com
(479) 802-3827 

有關更多新聞,請訪問在Facebook上為我們點贊1用於引用訪問2 2020年《國家糖尿病統計評論》衞生和公眾服務部疾病控制和預防中心
聯繫方式:
默裏·弗萊明
葡萄糖健康公司
郵箱:INFO@GIGROSEHANTHINC.com(479) 802-3827

This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and while Glucose Health, Inc. is not subject to the 1934 Securities and Exchange Act, contains forward-looking statements within the meaning Section 21E of the Securities and Exchange Act of 1934, as amended. Statements that are not a description of historical facts constitute forward-looking statements and may often, but not always, be identified by the use of such words as "expects," "anticipates," "intends," "estimates," "plans," "potential, "possible," "probable, "believes," "seeks," "may, "will, "should," "could" or the negative of such terms or other similar expressions. Actual results may differ materially from those set forth in this release due to the risks and uncertainties inherent in the Company's business. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement and the Company undertakes no obligation to revise or update this release to reflect events or circumstances after the date hereof.

本新聞稿包含符合修訂的1933年證券法第27A節的前瞻性陳述,雖然葡萄糖健康公司不受1934年證券交易法的約束,但包含符合1934年修訂的證券交易法第21E節的前瞻性陳述。不描述歷史事實的陳述構成前瞻性陳述,可能經常但不總是通過使用“預期”、“預期”、“打算”、“估計”、“計劃”、“可能”、“相信”、“尋求”、“可能”、“將”、“應該”、“可能”或此類術語的否定或其他類似表述來識別。由於公司業務中固有的風險和不確定性,實際結果可能與本新聞稿中陳述的結果大不相同。告誡讀者不要過度依賴這些前瞻性陳述,這些陳述僅在本文發表之日起發表。所有前瞻性陳述都受本警示聲明的限制,公司沒有義務修改或更新本新聞稿,以反映此後發生的事件或情況。


譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論